Shivroyal Life Care
Shivroyal Life Care


EMCURE ONCOLOGY

EMCURE ONCOLOGY

Vision is to manufacture innovative, high-tech products, which will satisfy the needs of customers. To this we are firmly committed. Technology and R&D play a vital role in all our endeavors. All our policies are market driven with the customer being the focal point. Emcure is committed to create brand equity by promoting top class products. In order to achieve this Vision, we undertake to create value for all the constituents we serve: our customers, consumers and the community. Emcure creates value by executing a comprehensive business strategy guided by the following key beliefs :
Our Company was incorporated as Emcure Pharmaceuticals Private Limited on April 16, 1981 as a private limited company under the Companies Act, 1956. We are a fast growing Indian pharmaceutical company engaged in developing, manufacturing and marketing a broad range of pharmaceutical products globally. Our core strength lies in developing and manufacturing differentiated pharmaceutical products in-house, which we commercialize through our marketing infrastructure across geographies and relationships with multi-national pharmaceutical companies. We are ranked as the 14th largest pharmaceutical company (Source: IMS Health India, Secondary Stockist Audit (“SSA”), March 2013) in India in terms of market share based on the domestic sales of pharmaceutical products. We believe that our competitive advantage in the domestic market lies in our established presence in all major therapeutic areas including blood related, cardiology, pain and analgesics, HIV, gynecology, nephrology, anti-infective, and vitamins, minerals and nutrients products. We have also recently entered the oncology and diabetes therapeutic areas. We have a well-diversified income base thanks to our business in the international markets. We have our own sales and marketing infrastructure in the United States through our subsidiary, Heritage. We sell our portfolio of branded generic products to the Rest of World. Our products are currently shipped to over 65 countries, where we have established our presence by focusing on important alliances with local and multi-national companies that enjoy a leadership position in the therapeutic areas on which we focus. We have subsidiaries in Dubai, Brazil, South Africa, Singapore and Nigeria and branch offices in Russia and Morocco. We focus our research and development efforts on developing a portfolio



Encicarb 100 Mg 2 Ml Injection Ferric Carboximaltose 100 Mg

Drug Interaction: Lactitol monohydrate is known to interact with other drugs like thiazodiuretics, corticosteroids, carbenoxolone, amphothericin B, neomycin. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Mechanism Of Action: Lactitol can increase the quantity of the beneficial bacteria and decrease the population of putrefactive bacteria selectively, reduce the intestinal pH, and lower the production and absorption of ammonia. Lactitol significantly increases Bifidobacterium and Lactobacillus.

Typical usage: Constipation, symptoms of irritable bowel syndrome.

Side Effects: Abdominal discomfort mainly flatulence and seldom, abdominal pain or sometimes an abdominal distension, diarrhea, pruritus ani, nausea, flatulence, gastrointestinal sounds abnormal.

Drug brand named Encicarb 100Mg Inj 1S is manufactured by EMCURE PHARMACEUTICALS LTD and mainly contents the generic drug Lactitol.
Package: 1SX1

Drug brand named Encicarb 100Mg Inj 1S is manufactured by EMCURE PHARMACEUTICALS LTD and mainly contents the generic drug Lactitol.
Package: 1SX1

Can we use Encicarb 100Mg Inj 1S during pregnency?

Pregnancy C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and wellcontrolled studies in humans but potential benefits may warrant use of the drug in pregnant women despite potential risks

Can we use Encicarb 100Mg Inj 1S during lactation?

Lactation L4 There is positive evidence of risk to a breastfed infant or to breastmilk production but the benefits of use in breastfeeding mothers may be acceptable despite the risk to the infant eg if the drug is needed in a lifethreatening situation or for a serious disease for which safer drugs cannot be used or are ineffective

For what type of diseases Encicarb 100Mg Inj 1S may be prescribed?

Pharmaceutical Aid

What are the known Side Effects of Encicarb 100Mg Inj 1S?

Nausea stomach upset skin rash acute toxicity

Precautions before taking Encicarb 100Mg Inj 1S

Tell your doctor of all prescription and nonprescription medication you may use Do not start or stop any medicine without doctor or pharmacist approval

Significance of Encicarb 100Mg Inj 1S


Encicarb 500 Mg Injection Ferric Carboximaltose

Drug Interaction: Lactitol monohydrate is known to interact with other drugs like thiazodiuretics, corticosteroids, carbenoxolone, amphothericin B, neomycin. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Mechanism Of Action: Lactitol can increase the quantity of the beneficial bacteria and decrease the population of putrefactive bacteria selectively, reduce the intestinal pH, and lower the production and absorption of ammonia. Lactitol significantly increases Bifidobacterium and Lactobacillus.

Typical usage: Constipation, symptoms of irritable bowel syndrome.

Side Effects: Abdominal discomfort mainly flatulence and seldom, abdominal pain or sometimes an abdominal distension, diarrhea, pruritus ani, nausea, flatulence, gastrointestinal sounds abnormal.

Supportive care is one of the most important co-treatment for the successful outcome of cancer patient management. Nearly 3/4th of cancer patients have anemia at some point or the other. They may require Iron supplementation, Erythropoietin Stimulating Agents, and blood transfusion. Blood transfusion is advised when the anemia is severe and there are known disadvantages of it. Of late, ESA usage in oncology has been reduced due to some concerns on increased risk of venous thromboembolism. IV iron has recently been recommended by guidelines for use in cancer associated anemia due to iron deficiency. There are several IV iron preparations. Ferric Carboxymaltose (Encicarb) is the closest to the ideal iron preparation and has the best tolerability profile as compared to others with the unique advantage of giving a total dose of a maximum 1000mg within a span of 15min.


Becoming a quality concentrated organization, we are distributing a unmatched range of Encicarb 100/500mg Injections. These are available at most competitive prices to the customers and we offer them for in an effective and dependable approach so that they can easily fulfill their needs and requirements.


Emgrast-m 500mg Injection Sargramostim

We are among the distinguished names in the industry, making available Emgrast M Injection to our esteemed customers. These emgrast M injection is widely in demand because of its being highly safe and effective. offered injection Highly demanded in the market.

Features:

  • Long shelf life
  • Protective packaging
  • Accurate composition
  
Payment Terms : T/T (Bank Transfer),Western Union,Other
FOB Price :
Port Of Dispatch : Mumbai
Production Capacity : 10000
Packaging Details : PayPal also accepted


Emgrast 300 Mcg Injection Filgrastim 300 MCG

Description

Emgrast (300 mcg) - Injection, manufactured by Emcure Pharmaceuticals Ltd. contains Generic Medicine Filgrastim- 300 mcg.
Emgrast (300 mcg)- Filgrastim- Injection costs about Rs.1 100.00 per 1 Vial in India as of date.
Compare the price of other similar medicines manufactured by other Pharma companies which contains the same Generic medicine - Emgrast (300 mcg) Filgrastim.

Drug Interaction: Tell your doctor or pharmacist of all prescription and nonprescription/herbal products you may use, especially of: blood pressure medications.Tell your doctor or pharmacist if you also take drugs that cause drowsiness such as: certain antihistamines (e.g., diphenhydramine), anti-seizure drugs (e.g.,carbamazepine), medicine for sleep or anxiety (e.g., alprazolam, diazepam,zolpidem), muscle relaxants, narcotic pain relievers (e.g., codeine), psychiatric medicines (e.g., chlorpromazine, risperidone, trazodone). Check the labels on all your medicines (e.g., cough-and-cold products) because they may contain ingredients that cause drowsiness.

Mechanism Of Action: Chemotherapy primarily refers to the treatment of cancer with an antineoplastic drug or with a combination of such drugs into a standardized treatment regimen. Certain chemotherapy agents also have a role in the treatment of other conditions, including ankylosing spondylitis, multiple sclerosis, Crohn's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis and scleroderma.The most common chemotherapy agents act by killing cells that divide rapidly, one of the main properties of most cancer cells. This means that chemotherapy also harms cells that divide rapidly under normal circumstances: cells in the bone marrow, digestive tract, and hair follicles. This results in the most common side-effects of chemotherapy: myelosuppression (decreased production of blood cells, hence also immunosuppression), mucositis (inflammation of the lining of the digestive tract), and alopecia (hair loss).

Typical usage: Mobilisation of peripheral blood progenitor cells for autologous peripheral blood stem cell transplantation. Congenital neutropaenia. Idiopathic or cyclic neutropenia. HIV infection and persistent neutropenia. Adjunct to antineoplastic therapy. Bone marrow transplantation.

Side Effects: Nausea, stomach upset, skin rash, acute toxicity. 

Premalignant or malignant myeloid condition, sickle-cell disease, osteoporotic bone disease, withdraw treatment if there are signs of pulmonary infiltrates.
Fluid retention or heart failure.
Monitor CBC and platelet count during therapy.
Monitor bone density in patients with osteoporosis (long term treatment) Regular morphological and cytogenic bone marrow examinations in severe congenital neutropenia.
Pregnancy and lactation.

 


Emgrast M 500 Mcg Injection Filgrastim M 500 Mcg

Description :
This drug should not be given within 24 hours of radiation or chemotherapy treatments. Your doctor will obtain blood tests as often as twice a week at first, to find out how you respond to the drug. Your doctor will adjust your dose or your medicines based on your test results. Keep all your appointments for doctor visits and blood tests. Some people have a reaction to the first dose of sargramostim that may include low blood pressure, fast heart rate, trouble breathing, flushing, or feeling dizzy or faint. Tell your doctor or nurse right away if you notice these symptoms so that they can be treated. Most often, a reaction to the first dose in a cycle is not a true allergic reaction and tends not to happen with future doses. This drug may affect the function of your liver and kidneys. These organs normally help filter the blood and help the body get rid of certain chemicals. Changes in these organs can change the blood levels of any other drugs you are taking. Your doctor will likely check the function of these organs with blood tests on a regular basis. The drug may need to be stopped or the dose reduced if the changes are severe. If you have kidney disease, liver metastasis, or other liver problems before starting treatment, the doctor may need to watch you more closely. In rare cases, some people who were given sargramostim reported shortness of breath, which is thought to be due to white blood cells building up in the blood vessels of the lungs. Tell your doctor or nurse right away if you begin to notice shortness of breath, cough, or fever. A rare but serious side effect is capillary leak syndrome, in which the small blood vessels in the body become leaky. This can allow fluid to leave the bloodstream and collect in other parts of the body. This could result in low blood pressure, fluid buildup, and poor blood flow to the internal organs. Tell your doctor right away if you feel dizzy or notice sudden swelling or rapid weight gain, trouble breathing, abnormal heart beats, chest pain, or little or no urine output. In rare cases, this drug can cause allergic reactions when the drug is given. Mild reactions may consist of fever, chills, skin itching, or feeling flushed. More serious reactions happen rarely, but can be dangerous. Symptoms can include feeling lightheaded or dizzy (due to low blood pressure), chest tightness, shortness of breath, back pain, or swelling of the face, tongue, or throat. Tell your doctor or nurse right away if you notice any of these symptoms during or after being given the drug.

How is this drug taken or given? Sargramostim may be given either as an infusion into a vein (intravenously, or IV) or as a shot under the skin (subcutaneously, or SubQ). It may be given in a hospital or doctor's office, or you or a family member can learn how to give the shot under the skin at home. The dose and treatment schedule will depend on your weight, general health, and the reason you are being treated. The dose and/or schedule may need to be adjusted based on how your body responds to treatment. If you are taking it at home, make sure to keep the medicine in its original container in the refrigerator. Take this drug exactly as directed by your doctor. If you are not sure of the instructions, ask your doctor or nurse to explain them to you. Keep the needles and other equipment in a safe place out of reach of children and pets. Keep used needles in a closed needle bucket and bring them back to your doctor or nurse.  


Biceltis 440 Mg Injection Trastuzumab 440 L Powder

Herceptin (trastuzumab) is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Trastuzumab is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary) culture containing the antibiotic gentamicin. Gentamicin is not detectable in the final product.

Herceptin is a sterile, white to pale yellow, preservative-free lyophilized powder for intravenous administration. Each multi-use vial of Herceptin contains 440 mg trastuzumab, 400 mg α,α-trehalose dihydrate, 9.9 mg L-histidine HCl, 6.4 mg L-histidine, and 1.8 mg polysorbate 20, USP. Reconstitution with 20 mL of the appropriate diluent (BWFI or SWFI) yields a solution containing 21 mg/mL trastuzumab, at a pH of approximately 6.

Our firm is one of the primary names in industry, participated in processing a wide range of Biceltis 440mg Injections. We have used in produced these injections and state-of-the-art technology methodologies that make sure their trustworthiness and the best possible quality materials.

Do not use this medication without telling your doctor if you are pregnant. It could harm the unborn baby. Use effective birth control, and tell your doctor if you become pregnant during treatment.

Before receiving trastuzumab, tell your doctor if you have heart disease, congestive heart failure, a history of heart attack, or any allergies or breathing problems. You may not be able to receive trastuzumab, or you may need a dosage adjustment or special tests during treatment.

Some people receiving a trastuzumab injection have had a reaction to the infusion (when the medicine is injected into the vein). Tell your caregiver right away if you feel dizzy, nauseated, light-headed, weak, itchy, or short of breath during the injection.

Before using trastuzumab, tell your doctor or pharmacist if you are allergic to it; or to other mouse protein medications; or if you have any other allergies. This product may contain inactive ingredients (such as benzyl alcohol), which can cause allergic reactions or other problems. Talk to your pharmacist for more details.

Before using this medication, tell your doctor or pharmacist your medical history, especially of: previous cancer treatments (including radiation therapy to the chest), current infection, virus infection with returning symptoms (e.g., herpes, shingles), heart disease, high blood pressure, lung problems, previous severe reaction to monoclonal antibody treatment.

Do not have immunizations/vaccinations without the consent of your doctor, and avoid contact...


Ikgdar Injection Rituximab 500 Mg

Description:

  • Non-hodgkin’s lymphoma (nhl)
  • Chronic lymphocytic leukemia (cll)
  • Rheumatoid arthritis (ra)
  • Granulomatosis with polyangiitis (gpa)
Our firm is amid the top level in the marketplace, committed in distributing an accurately composed range of Ikgdar 100/500mg Injections. The products we offer to our clients are quality analyzed and are based to their particular needs. It can be easily availed at market cost-effective rates.
With the assistance of our sincere and experienced professionals, we have been able to establish ourselves as a prominent firm, involved in trading and exporting a broad range of Ikgdar 500 mg Injections. These injections are widely used with or without other medicines for treating non-Hodgkin's lymphoma as well as symptoms of rheumatoid arthritis. Formulated with qualitative ingredients, offered Ikgdar 500 mg Injections are demanded across the globe for their effectiveness and safety from side effects.
Precautions

Rituximab is contraindicated in patients with immune e disorders, renal diseases, hepatic diseases including hepatitis B infections, breathing disorders, active infections, SLE, recent history of angina and heart rhythm disorder.

Special Precautions

No information available

Other Drug Interactions

Rituximab may interact with biologics including anti-TNF-alpha blockers.

Other Interactions

No information available

Dosage

For Non-Hodgkin's lymphoma and refractory or relapsed forms of follicular lymphoma (Adults):
As an intravenous infusion, consider administration of 375 mg/m2 at the rate of 50 mg/hr, four doses, once a week. Based on the toleration and clinical response, the dosage can be increased to 100 mg/hr. The maximum dose should not exceed 400 mg/hr.
As a combined therapy with chemotherapy, consider administration of 375 mg/m2 on day one of each 21-days chemotherapy cycle. In responsive cases, 6-8 cycles can be considered. For maintenance, consider 375 mg/m2 once weekly for 4 doses and the dosage can be repeated (6 doses/month, up to 16 doses)

For rheumatoid arthritis (Adults):
Consider administration of 1g of infusion, four doses, with two weeks apart.

Food(before/after)

May be taken with or without food

List of Contraindications Rituximab and Pregnancy

USFDA pregnancy category C. May be or may not be harmful to an unborn baby. Consult your doctor if you are in gestation or planning to have a baby during Rituximab treatment. Use effective contraceptive mode for at least 12 months after discontinuation of Rituximab treatment.

Rituximab and Lactation

It is not known whether Rituximab can pass through the breast milk or not. Nursing mothers should avoid breastfeeding while taking Rituximab.

Rituximab and Children

No information available

Rituximab and Geriatic

No specific information

Rituximab and Other Contraindications

No specific information

Storage

Store at 20-25°C.


Ikgdar Injection Rituximab 100 Mg

We are one of the leading exporter, supplier, distributor, wholesaler, trader and importers of a wide range of Ikgdar 100 mg /10 ml and 500 mg/ 50 ml that are formulated by using safe and pure ingredients. These medicines are made available in various packaging options to suit the varied demands and specifications of the clients.

Precautions

Rituximab is contraindicated in patients with immune e disorders, renal diseases, hepatic diseases including hepatitis B infections, breathing disorders, active infections, SLE, recent history of angina and heart rhythm disorder.

Special Precautions

No information available

Other Drug Interactions

Rituximab may interact with biologics including anti-TNF-alpha blockers.

Other Interactions

No information available

Dosage

For Non-Hodgkin's lymphoma and refractory or relapsed forms of follicular lymphoma (Adults):
As an intravenous infusion, consider administration of 375 mg/m2 at the rate of 50 mg/hr, four doses, once a week. Based on the toleration and clinical response, the dosage can be increased to 100 mg/hr. The maximum dose should not exceed 400 mg/hr.
As a combined therapy with chemotherapy, consider administration of 375 mg/m2 on day one of each 21-days chemotherapy cycle. In responsive cases, 6-8 cycles can be considered. For maintenance, consider 375 mg/m2 once weekly for 4 doses and the dosage can be repeated (6 doses/month, up to 16 doses)

For rheumatoid arthritis (Adults):
Consider administration of 1g of infusion, four doses, with two weeks apart.

Food(before/after)

May be taken with or without food

List of Contraindications Rituximab and Pregnancy

USFDA pregnancy category C. May be or may not be harmful to an unborn baby. Consult your doctor if you are in gestation or planning to have a baby during Rituximab treatment. Use effective contraceptive mode for at least 12 months after discontinuation of Rituximab treatment.

Rituximab and Lactation

It is not known whether Rituximab can pass through the breast milk or not. Nursing mothers should avoid breastfeeding while taking Rituximab.

Rituximab and Children

No information available

Rituximab and Geriatic

No specific information

Rituximab and Other Contraindications

No specific information

Storage

Store at 20-25°C.


Consium 100mg Injection ( Carmustine )

Description :

Brand Name- Consium

Generic Name - Carmustine    Why would this drug be used? Carmustine is used to treat Hodgkin and non-Hodgkin lymphoma, multiple myeloma, and other types of cancer. The implantable wafer that contains carmustine is used to treat gliomas, which are a type of brain tumor.   How does this drug work? Carmustine acts as an alkylating agent that can damage DNA to keep cancer cells from growing. It.is in a general group of alkylating chemotherapy drugs called nitrosoureas. It helps to stop cancer cells from growing and causes them to die.

Before taking this medicine Tell your doctor… If you are allergic to anything, including medicines, dyes, additives, or foods. If you have any medical conditions such as kidney disease, liver disease (including hepatitis), heart disease, congestive heart failure, diabetes, gout, or infections. These conditions may require that your medicine dose, regimen, or timing be changed. If you have lung disease or reduced lung capacity. This can increase your risk of lung scarring (fibrosis.) If you have ever been treated for cancer with radiation or chemotherapy. Some of these treatments may affect your response to this medicine. If you are pregnant, trying to get pregnant, or if there is any chance of pregnancy. This drug may cause birth defects if either the male or female is taking it at the time of conception or during pregnancy. Men and women who are taking this drug need to use some kind of birth control. Check with your doctor about what kinds of birth control can be used with this medicine. If you are breast-feeding. It is not known whether this drug passes into breast milk. If it does, it could harm the baby. If you think you might want to have children in the future. Some drugs can affect fertility. Talk with your doctor about the possible risk with this drug and options that may preserve your ability to have children. About any other prescription or over-the-counter medicines you are taking, including vitamins and herbs. In fact, keeping a written list of each of these medicines (including the doses of each and when you take them) with you in case of emergency may help prevent complications if you get sick.   How is this drug taken or given? Carmustine is infused into the vein (I.V.) over 1 to 2 hours. It can be given based on several different schedules, although it is generally given no more often than every 6 weeks. The dose depends upon your size but may be lowered, delayed, or not given if your blood counts are low. You will get anti-nausea medicine before you get carmustine.


Other Information

  • Pay Mode Terms: L/C (Letter of Credit), D/P (Documents Against Payment), T/T (Bank Transfer), Western Union, Other




Contact Us

Shivroyal Life Care
Mr. Suresh Deve (Proprietor)
Shop No. 4, Anant Niwas, Near Veterinary College, Dr. Vijay Kumar Walimbe Marg, Parel Village, Parel, Landmark- Opposite Kem Hospital, Gate No. 7
Mumbai - 400012, Maharashtra, India



Home  |  Profile  |  Our Products  |  Trade Offers (12)  |  Site Navigation  |   Contact Us

© Shivroyal Life Care. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited